Article
Drug development progress in duchenne muscular dystrophy
22 Jul 2022
Abstract excerpt
Duchenne muscular dystrophy (DMD) is a severe, progressive, and incurable X-linked disorder caused by mutations in the dystrophin gene. Patients with DMD have an absence of functional dystrophin protein, which results in chronic damage of muscle fibers during contraction, thus leading to deterioration of muscle quality and loss of muscle mass over time. Although there is currently no cure for DMD, improvements in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
